Atlas Trials

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

Clinical trial NCT03957733 · UNKNOWN

Trial details

NCT number
NCT03957733
Sponsor
King Abdullah Medical City
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2017-11-23
Primary completion
2022-05-30
Enrollment
338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.